Home Health Care News June 23, 2021
Health care dealmaking is on a blistering pace in 2021, with particular action around the home health and hospice spaces.
And while transactions are being driven by private equity firms with plenty of dry powder, they’re also propelled by regulatory shifts, emerging care models and the transformation of the sector, a new mid-year dealmaking report from PricewaterhouseCoopers (PwC) reveals.
“Pandemic progress means dealmakers are starting to refocus on pursuing competitive advantage,” Nick Donkar, PwC’s U.S. health services deals leader, wrote in the report. “We see investors adding capabilities and rethinking ecosystems, with a laser focus on value and patient-centricity.”
With at least 352 health care deals, the fourth quarter of 2020 saw the highest quarterly deal volume ever, according to...